Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Low-glycemic index diets are beneficial for weight loss and satiety, but more research is needed on long-term effects and individualized approaches are recommended.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Minoxidil causes excessive hair growth, but depilatory agent removes it safely and effectively.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Finasteride safely reduces excessive hair growth in women.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

Psychotropic medications can cause skin problems but also treat some skin conditions.

ALA-photodynamic therapy helps reduce acne by causing acne cell death and lowering certain skin protein levels.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.